(Q36573247)

15 August 2017

1 reference

title

Regulation of NF-kappaB signaling by decoy oligodeoxynucleotides (English)

1 reference

15 August 2017

0 references

Iwao Isomura

1

1 reference

15 August 2017

Akimichi Morita

series ordinal

2

1 reference

15 August 2017

publication date

1 January 2006

1 reference

Microbiology and Immunology

15 August 2017

published in

1 reference

15 August 2017

volume

50

1 reference

15 August 2017

issue

8

1 reference

15 August 2017

page(s)

559-563

1 reference

Transfection of NFkappaB-decoy oligodeoxynucleotides using efficient ultrasound-mediated gene transfer into donor kidneys prolonged survival of rat renal allografts

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03827.X

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03827.X

Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03827.X

Nuclear factor (NF)-kappa B2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03827.X

Enhanced intracellular uptake and inhibition of NF-kappaB activation by decoy oligonucleotide released from PLGA microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03827.X

Selective blockade of NF-kappa B activity in airway immune cells inhibits the effector phase of experimental asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03827.X

Treatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF-kappa B decoy oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03827.X

Genetic approaches in mice to understand Rel/NF-kappaB and IkappaB function: transgenics and knockouts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03827.X

The regulation and roles of Rel/NF-kappa B transcription factors during lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03827.X

Prolongation of cardiac allograft survival using dendritic cells treated with NF-kB decoy oligodeoxyribonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03827.X

Anti-inflammatory gene therapy directed at the airway epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03827.X

c-Rel regulates interleukin 12 p70 expression in CD8(+) dendritic cells by specifically inducing p35 gene transcription.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03827.X

B lymphocytes differentially use the Rel and nuclear factor kappaB1 (NF-kappaB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03827.X

Ultrasound-microbubble-mediated NF-kappaB decoy transfection attenuates neointimal formation after arterial injury in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03827.X

NF-kappaB regulation in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03827.X

Therapeutic applications of transcription factor decoy oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03827.X

In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03827.X

Prevention and regression of atopic dermatitis by ointment containing NF-kB decoy oligodeoxynucleotides in NC/Nga atopic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03827.X

Dendritic cell survival and maturation are regulated by different signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03827.X

NF-kappaB: a key role in inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03827.X

Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03827.X

Prolongation of liver allograft survival by dendritic cells modified with NF-kappaB decoy oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03827.X

Inhibition of intimal hyperplasia after balloon injury in rat carotid artery model using cis-element 'decoy' of nuclear factor-kappaB binding site as a novel molecular strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03827.X

10.1111/J.1348-0421.2006.TB03827.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference